Bioresorbable Medical Material Market Report 2025

The bioresorbable medical material market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to traditional non-resorbable materials limitations, advancements in polymer science, surge in cardiovascular interventions, growing aging population, expansion of minimally invasive surgeries.

The bioresorbable medical material market size is expected to see rapid growth in the next few years. It will grow to $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to increasing demand for bioresorbable scaffolds, adoption of bioresorbable materials in various medical applications, rise in cardiovascular and orthopedic procedures, growing focus on patient comfort and recovery, expanding applications in tissue engineering. Major trends in the forecast period include customization of bioresorbable materials for specific medical applications, integration of bioresorbable materials in drug delivery systems, growth of 3d printing in bioresorbable medical device manufacturing, development of combination products with bioresorbable elements, emphasis on sustainable and environmentally friendly medical materials,.

The rising number of surgeries is expected to drive the growth of the bioresorbable medical material market in the future. Surgical procedures involve medical treatments that require making an incision and utilizing tools to address or repair diseases within a living body. Bioresorbable polymers are utilized in molded medical devices, especially in the fields of neurology, orthopedics, and cosmetic surgery. These materials can be employed to manufacture sutures, anchors, and screws. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures approached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Consequently, the growing number of surgeries is fueling the growth of the bioresorbable medical material market.

The burgeoning aging population is poised to drive the growth of the bioresorbable medical material market significantly. An aging population signifies a demographic shift marked by a higher percentage of individuals aged 65 and above within a society. The increased demand for medical interventions among the elderly, coupled with a preference for advanced bioresorbable solutions that alleviate the necessity for subsequent surgeries to remove implants, fuels the expansion of the bioresorbable medical materials market. For instance, in 2022, according to visual capitalist, a Canadian company specializing in visual content on contemporary trends, the global population aged 65+ years totaled 771 million, accounting for nearly 10% of the world’s populace. Therefore, the growing aging demographic is a key driver behind the growth of the bioresorbable medical material market.

The emergence of innovative biomaterials is a significant trend gaining traction in the bioresorbable medical material market. Key players in this sector are concentrating on creating new biomaterials for 3D printing applications to maintain their market presence. For example, in September 2023, Zeus, a South Carolina-based company known for its advanced polymer solutions across various industries, including medical, aerospace, energy, automotive, and fiber optics, introduced next-generation tubing for bioresorbable vascular scaffolds called Absorv™ XSE. This product aims to enhance medical device capabilities, especially in vascular treatments. Absorv™ XSE represents a major advancement in bioresorbable medical devices, potentially improving patient outcomes and broadening treatment options. This innovative offering allows for extensive customization with a variety of polymer choices and expanded sizes, which facilitate tailored mechanical and absorption properties. It also ensures improved wall thickness uniformity for consistent production and provides approximately 25% more usable scaffolds post-laser cutting compared to previous models.

Leading companies in the bioresorbable medical material market are focusing on new product launches to gain a competitive advantage. For instance, in October 2023, Ashland Global, a US-based chemicals company, unveiled its bioresorbable polymers technology platform. This adaptable platform can be extended across various market segments and applications, including long-acting injectables for chronic disease management and animal health, advanced drug delivery systems to enhance mRNA delivery, as well as applications in medical devices and regenerative medicine, such as dermal fillers, sutures, screws, and other products.

In April 2024, ProMed Pharma, a US-based contract manufacturer specializing in polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera for an undisclosed sum. This acquisition is strategically aimed at bolstering ProMed Pharma's market position by enhancing its manufacturing capabilities, broadening its product range, and supporting innovative drug development efforts. SpineThera is a US-based clinical-stage pharmaceutical company focused on creating innovative injectable drugs, particularly through its proprietary micro-suspension platform technology.

Major companies operating in the bioresorbable medical material market include Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

North America was the largest region in the bioresorbable medical material market in 2024. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioresorbable medical material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Bioresorbable medical materials are substances specifically engineered to be absorbed or broken down by the body over time. These materials find applications in various medical scenarios, including surgical implants and tissue engineering scaffolds. They offer several advantages compared to permanent implants, as they eliminate the need for surgical removal once they have fulfilled their intended function.

The primary types of bioresorbable medical materials include polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane. PLA is commonly utilized in the production of bioresorbable medical materials, such as sutures, screws, and bone fixation devices. These materials serve diverse applications, including drug delivery and orthopedics, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and research institutes.

The bioresorbable medical material research report is one of a series of new reports that provides bioresorbable medical material market statistics, including the bioresorbable medical material industry's global market size, regional shares, competitors with a bioresorbable medical material market share, detailed bioresorbable medical material market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. This bioresorbable medical material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are ‘factory gat’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.